Drug resistance patterns in new and previously treated patients with tuberculosis presenting to a tertiary care center in southern India by Anto J Udaykumar et al.
ORAL PRESENTATION Open Access
Drug resistance patterns in new and previously
treated patients with tuberculosis presenting to a
tertiary care center in southern India
Anto J Udaykumar1, Jayashree R2, Baijayanti Mishra2, Rosario Vivek1, John Kenneth1*
From 2nd International Science Symposium on HIV and Infectious Diseases (HIV SCIENCE 2014)
Chennai, India. 30 January - 1 February 2014
Background
Tuberculosis (TB) caused by Mycobacterium tuberculosis
remains a major global health problem. It is the second
leading cause of death worldwide. Drug resistance threa-
tens global TB control with the emergence of multidrug
resistant (MDR) and extensively drug resistant (XDR)
TB. The burden of MDR TB and XDR TB in India is not
available as continuous surveillance for drug resistance is
not carried out. This study was done to determine the
drug resistance patterns to first and second line drugs
among new and previously treated patients with TB.
Methods
Sputum samples were collected from 100 suspected TB
patients from a tertiary care referral hospital. After diges-
tion and decontamination, samples were stained for
microscopy and cultured in liquid (MGIT) and Löwen-
stein Jensen (LJ) medium to isolate M. tuberculosis. Drug
susceptibility testing (DST) was done against first line
(streptomycin, isoniazid, rifampin and ethambutol) and
second line (kanamycin, capreomycin, ofloxacin and
ethionamide) drugs.
Results
Among the 100 samples, 56 were smear positives and
M. tuberculosis was isolated from 61 samples cultured in
MGIT and 46 in L J medium. Of which 20 (32.7%) were
MDR strains. Among the MDR strains, 9 (45%) were XDR
strains. Two strains were totally resistant to all the
8 drugs. The proportion of MDR and XDR was highest
among the previously treated patient.
Conclusion
This study underscores the need for DST in all TB
patients particularly in the previously treated patients.
New drugs, novel treatment strategies and adherence to
treatment are needed to effectively treat and control drug
resistant TB.
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